tiprankstipranks
CervoMed announces key takeaways from presentations on neflamapimod
PremiumThe FlyCervoMed announces key takeaways from presentations on neflamapimod
17d ago
CervoMed to Present Phase 2b Trial Results
Premium
Company Announcements
CervoMed to Present Phase 2b Trial Results
22d ago
CervoMed to present at International Lewy Body Dementia Conference
Premium
The Fly
CervoMed to present at International Lewy Body Dementia Conference
23d ago
CervoMed initiated with a Buy at Chardan
PremiumThe FlyCervoMed initiated with a Buy at Chardan
2M ago
CervoMed Updates Investors on Business and Clinical Progress
Premium
Company Announcements
CervoMed Updates Investors on Business and Clinical Progress
3M ago
CervoMed reports Q2 EPS (27c), consensus (45c)
Premium
The Fly
CervoMed reports Q2 EPS (27c), consensus (45c)
3M ago
Lockheed Martin upgraded, L3Harris downgraded: Wall Street’s top analyst calls
PremiumThe FlyLockheed Martin upgraded, L3Harris downgraded: Wall Street’s top analyst calls
4M ago
CervoMed initiated with an Overweight at Morgan Stanley
Premium
The Fly
CervoMed initiated with an Overweight at Morgan Stanley
4M ago
CervoMed Discusses Neflamapimod in Virtual Investor Event
Premium
Company Announcements
CervoMed Discusses Neflamapimod in Virtual Investor Event
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100